Showing 241 - 260 results of 4,859 for search 'RPAF~', query time: 2.36s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245

    A Man of Vision by Muriel Verbeeck-Boutin

    Published 2019-12-01
    Subjects:
    Get full text
    Article
  6. 246
  7. 247

    Hepatic Stellate Cell-Derived Microvesicles Prevent Hepatocytes from Injury Induced by APAP/H2O2 by Renwei Huang, Qunwen Pan, Xiaotang Ma, Yan Wang, Yaolong Liang, Bingyan Dai, Xiaorong Liao, Mingyi Li, Huilai Miao

    Published 2016-01-01
    “…The aim of this study was to investigate the effect of HSC-derived MVs on xenobiotic-induced liver injury. Rat and human hepatocytes, BRL-3A and HL-7702, were used to build hepatocytes injury models by n-acetyl-p-aminophenol n-(APAP) or H2O2 treatment. …”
    Get full text
    Article
  8. 248
  9. 249

    How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications by Catherine E. Bond, Vicki L. J. Whitehall

    Published 2018-01-01
    “…The BRAF oncogene is an integral component of the MAP kinase pathway, and an activating V600E mutation occurs in 15% of sporadic colorectal cancer. …”
    Get full text
    Article
  10. 250
  11. 251

    CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma by Victoria Jennings, Kevin Harrington, Hardev Pandha, Alan Melcher, Adel Samson, Fiona Errington-Mais, Victoria Roulstone, Eva Crespo-Rodriguez, Galabina Bozhanova, Shane Foo, Emmanuel C Patin, Martin McLaughlin, Malin Pedersen, Richard Vile, Joan Kyula, Jehanne Hassan, Lizzie Appleton, Charleen ML Chan Wah Hak, Gabby Baker, Edward Armstrong, Matthew Chiu, Masahiro Ono

    Published 2022-03-01
    “…Background Combination herpes simplex virus (HSV) oncolytic virotherapy and BRAF inhibitors (BRAFi) represent promising immunogenic treatments for BRAF mutant melanoma, but an improved understanding of the immunobiology of combinations is needed to improve on the benefit of immune checkpoint inhibitors (ICI).Methods Using a BRAFV600E-driven murine melanoma model, we tested the immunogenicity of HSV/BRAFi in immunocompetent C57BL mice. …”
    Get full text
    Article
  12. 252

    The Effect of Puncture Sites of Portal Vein in TIPS with ePTFE-Covered Stents on Postoperative Long-Term Clinical Efficacy by Si-liang Chen, Peng Hu, Zhi-peng Lin, Jian-bo Zhao

    Published 2019-01-01
    “…Choosing the left branch of the portal vein as the puncture site to create the shunt in TIPS with ePTFE-covered stents may decrease the incident of primary restenosis and HE significantly.…”
    Get full text
    Article
  13. 253
  14. 254
  15. 255

    Myeloid cell-derived apCAFs promote HNSCC progression by regulating proportion of CD4+ and CD8+ T cells by Feilong Ren, Lin Meng, Shize Zheng, Jiasen Cui, Shaoyi Song, Xing Li, Dandan Wang, Xing Li, Qilin Liu, Wenhuan Bu, Hongchen Sun

    Published 2025-01-01
    “…Our current study tried to explore the origin, mechanism, and function of the apCAFs in the HNSCC. Data from single-cell transcriptomics elucidated the presence of apCAFs in the HNSCC. …”
    Get full text
    Article
  16. 256
  17. 257
  18. 258
  19. 259

    Log-Driven Behavior Discrimination of Process Robots Using Entropy Similarity by Lu Li, Huan Fang

    Published 2025-01-01
    Subjects: “…Robotic process automation (RPA)…”
    Get full text
    Article
  20. 260

    AI-Enhanced Robotic Process Automation: A Review of Intelligent Automation Innovations by Sadia Afrin, Shobnom Roksana, Riad Akram

    Published 2025-01-01
    Subjects: “…intelligent process automation (IPA)…”
    Get full text
    Article